Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in people with ...

Patients on the higher dose of 7.2 milligrams for about 18 months lost 21% of their body weight on average, a study found.

Patients who took an experimental drug from Eli Lilly and Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while losing weight, offering a potential solution to one of the key problems ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has approved a new pill version of the weight-loss drug Wegovy - Novo Nordisk The US Food and Drug Administration on ...

Novo Nordisk is planning a major markdown on two of the hottest drugs in medicine, though not for another year. The Danish ...

Competition is heating up in the GLP-1 space.

The weight loss medication Wegovy is now available as a pill. The starting doses arrived at pharmacies across the country on Monday. Higher doses will ship out by the end of the week. NPR ...

The stock this week wiped out the last of the yearslong surge that followed the 2021 US approval of its Wegovy obesity drug, after a next-generation shot delivered less weight loss than that of its ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Novo Nordisk received final approval for a higher dose of its Wegovy weight-loss shot from the European Commission. Approval of the higher 7.2 milligram dose of Wegovy means that doctors in the EU can ...